Obesity, Oral Contraception, and Ovarian Suppression

Completed · Phase 4

Conditions studied: Ovarian Suppression

In brief

This study proposes a double blind randomized clinical trial to include normal weight and obese women who have normal ovulatory function at baseline; the investigators will randomize women to 2 widely used OCs and evaluate ovarian follicle development and circulating progesterone to assess ovarian suppression during OC use.

Key facts

Study ID

NCT00827632

Run by

Columbia University

People needed

226

Starts

2006-07-01

Expected to finish

2008-12-01

Last updated by the study team

2019-04-30

Who can join

Age: 18 and older, up to 35. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Aged 18-35
• Body Mass Index (BMI) 19-24.9 or 30-39.9 kg/m\^2
• Willing to take birth control pills for 3-4 months
• Recent spontaneous pregnancy or cyclic menses

You may not qualify if…

• Contraindications to hormonal contraceptives
• Oophorectomy/Polycystic ovary syndrome (PCOS)
• Taken oral contraceptives to regulate menses recently
• Weight reduction surgery
• Used Depo-Provera within the last 12 months
• Pregnant or currently breastfeeding
• Desiring pregnancy within the next 4 months
• Unable to make study visit commitment
• Previous participation in this study

Where it is running

• Columbia University Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.